Outcomes associated with a pediatric clinical diabetes network in Ontario: a population-based time-trend analysis

Meranda Nakhla1, Elham Rahme1, Marc Simard1

  • 1Affiliations: Department of Pediatrics (Nakhla), The Montreal Children's Hospital, McGill University; Research Institute of the McGill University Health Centre (Nakhla, Rahme), Montréal, Que.; Institut national de santé publique du Québec (Simard), Québec, Que.; Department of Pediatrics (Guttmann), The Hospital for Sick Children, University of Toronto; Institute of Health Policy, Management and Evaluation (Guttmann), University of Toronto; Institute for Clinical Evaluative Sciences (Guttmann), Toronto, Ont.

CMAJ Open
|July 28, 2017
PubMed

Insights

Implementing a pediatric diabetes network in Ontario reduced acute complications for children with diabetes. The network improved outcomes, especially for those with lower socioeconomic status, though rural disparities persist.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Health Services Research

Background:

  • The Network of Ontario Pediatric Diabetes Programs was established in 2001.
  • This study evaluated its impact on acute diabetes-related complications and disparities.

Purpose of the Study:

  • To assess if the pediatric diabetes network decreased acute complications.
  • To determine if the network reduced socioeconomic and geographic disparities in outcomes.

Main Methods:

  • Population-based time trend analysis of children (<18 years) with diabetes in Ontario (1996-2011).
  • Used health administrative data and linear mixed-effects models to analyze emergency department visits and hospital admissions.

Main Results:

  • Significant decrease in emergency department visits (17.0 to 10.00 per 100 children) and hospital admissions (8.8 to 5.0 per 100 children) post-network implementation (p < 0.001).
  • Greatest decrease observed in lowest socioeconomic quintile and urban areas.
  • Disparities in outcomes between lowest and highest socioeconomic quintiles decreased (p < 0.05).
  • Urban patients had lower emergency visit risk than rural patients post-implementation.

Conclusions:

  • Pediatric diabetes network establishment led to improved health outcomes, particularly for lower socioeconomic status patients.
  • Further research is needed to address healthcare needs in rural pediatric diabetes populations.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289